Key Features
- Incorporates compelling biological activity data and preclinical
structure-activity relationships to help you choose promising lead
molecules for further research
- Includes primary source references to the most recent natural
product discoveries in the field of neuroprotection in order to promote
new drug discovery in this area
- Contains detailed discussions of important neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease
- Each plant section includes a critical evaluation of
pharmacological, chemical, and toxicological evidence to support the use
of the compound in drug discovery research in neurodegeneration
Description
Lead Compounds from Medicinal Plants for the Treatment of Neurodegenerative Diseases is the second volume in the series,
Pharmaceutical Leads from Medicinal Plants.
This book includes key pharmacological and chemical evidence to support
the selection of promising pre-clinical candidates for the treatment of
neurodegenerative diseases.
This important addition to the natural product and drug discovery
literature contains the history, synonyms, medicinal uses,
phytopharmacology, pre-clinical potential, and rationale for each plant
selected. By providing critical evaluation of pharmacological data,
mechanisms of action, and structural requirements for the development of
future neuroprotective agents, this comprehensive reference is a
beneficial resource for industry and academic scientists whose research
focuses on neurodegenerative drug discovery and development.
Readership
Pharmaceutical scientists and neuroscientists involved in
Central Nervous System drug discovery in both industry and academic
settings
